Cell therapy platform developing treatments for incurable eye diseases.
| Date | Round | Amount |
|---|---|---|
| Aug 2022 | Series A Biotech startup Eyestem raised $6.4M in a Series A led by Biological E, Alkem and NATCO, with Endiya Partners and Kotak PE participating. | $6.4M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.